After an incredible response to our flagship symposium, we present to you the second edition “Stem Cells & Cancer – India 2019” symposium with theme of etection and Therapeutic interventions of Stem cells in Cancer. This edition will witness researchers & clinicians presenting their exciting work & case studies to the forum on:
India 2019 will encompass recent researches and findings in Cancer stem cells technologies , Cancer stem cells therapies and transplantation and other advancements in Cancer stem cells research.
Stem Cells & Cancer – India 2019 will be a great platform for research scientists and young researchers to share their current findings in this field of applied science. The scientific sessions will focus on the latest and exciting innovations in prominent areas of Cancer cell science and Cancer stem cells research.
Stem Cells & Cancer – India 2019 invites all the participants from all over the world to attend the 2nd edition of the symposium on 1st February 2019 in Mumbai, India which includes prompt keynote presentations, oral talks, poster presentations and exhibitions.
Eminent personalities, Directors, CEO, President, Vice-president, Organizations, Associations Heads and Professors, Clinicians, Research scientists, Cancer Stem Cell laboratory heads, Post-docs, Students other affiliates related to the area of Cancer Stem cells research and regenerative medicine.
Friday, February 1st, 2019 at 8:00 AM to 5:45 PM
scheduled to be held at Mumbai, India on February 1st 2019. Stem Cells & Cancer – India 2019 Congress will witness the social affair of globally renowned specialists engaged with Cancer Research & Oncology such as Oncologists, Pharmacologists, Clinicians, Healthcare Professionals, Researchers, Academicians, Students and Business Delegates.
This edition will focus primarily on the theme “Detection and Therapeutic interventions of Stem cells in Cancer”.
The symposium will host Dr. Christopher J Logothetis, a pioneer in prostate cancer treatment. Dr. Christopher J. Logothetis has a longstanding interest in genitourinary cancers—germ cell tumors, bladder, renal, and most recently in his career, prostate cancer.
His research experience preceded the development of effective chemotherapy and extends to the current era of molecular targeted therapies and classification of cancer. He was among the first to test chemotherapy agents at a time of general skepticism that
chemotherapy would be useful in advanced prostate cancer.
Stem Cells & Cancer – India 2019 is a gathering for International medicinal health experts, Pharmacologists and Oncologists to encourage the dissemination and utilization of research discoveries related with Cancer. The symposium welcomes members from leading Universities, Clinical Research Institutions, Academicians, Oncologists, Consultants, Scholars, Business Delegates, Drug anufacturers and analytic organizations to share their exploration encounters on all aspects of this rapidly growing field and accordingly, giving a showcase of the most recent strategies.